Literature DB >> 14505768

Cross-cultural evaluation of the Parkinson's Disease Questionnaire: tests of data quality, score reliability, response rate, and scaling assumptions in the United States, Canada, Japan, Italy, and Spain.

Crispin Jenkinson1, Ray Fitzpatrick, Josephine Norquist, Leslie Findley, Kim Hughes.   

Abstract

BACKGROUND AND OBJECTIVES: Health status measures, used to measure the subjective functioning and well-being of respondents, are increasingly being used in trials of treatments that are undertaken in a variety of countries. To assess comparability of results gained from such cross-cultural studies, it is important for researchers to know the comparability of instruments across cultures. One measure widely used in cross-cultural studies is the Parkinson's Disease Questionnaire (PDQ-39). We evaluated response rate, data quality, score reliability, and scaling assumptions of the instrument in the United States, Canada, Spain, Italy, and Japan.
METHODS: Our data were gained from the Global Parkinson's Disease Survey, a cross-national survey, in which the PDQ-39 was interviewer administered to respondents.
RESULTS: Our data suggest that the PDQ-39 is, for the most part, a valid and reliable measure that can be appropriately and meaningfully used in cross-cultural studies. However, one of the dimensions of the measure, Social Support, may not be sufficiently reliable to be used as a primary endpoint in trials.
CONCLUSION: The PDQ-39 seems to be sufficiently robust to be used in trials and surveys in cross-cultural studies.

Entities:  

Mesh:

Year:  2003        PMID: 14505768     DOI: 10.1016/s0895-4356(03)00148-3

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  11 in total

1.  The 39-Item Parkinson's Disease Questionnaire (PDQ-39): Is it a Unidimensional Construct?

Authors:  Peter Hagell; Maria H Nilsson
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

2.  Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.

Authors:  Karl Kieburtz; Barbara C Tilley; Jordan J Elm; Debra Babcock; Robert Hauser; G Webster Ross; Alicia H Augustine; Erika U Augustine; Michael J Aminoff; Ivan G Bodis-Wollner; James Boyd; Franca Cambi; Kelvin Chou; Chadwick W Christine; Michelle Cines; Nabila Dahodwala; Lorelei Derwent; Richard B Dewey; Katherine Hawthorne; David J Houghton; Cornelia Kamp; Maureen Leehey; Mark F Lew; Grace S Lin Liang; Sheng T Luo; Zoltan Mari; John C Morgan; Sotirios Parashos; Adriana Pérez; Helen Petrovitch; Suja Rajan; Sue Reichwein; Jessie Tatsuno Roth; Jay S Schneider; Kathleen M Shannon; David K Simon; Tanya Simuni; Carlos Singer; Lewis Sudarsky; Caroline M Tanner; Chizoba C Umeh; Karen Williams; Anne-Marie Wills
Journal:  JAMA       Date:  2015-02-10       Impact factor: 56.272

3.  Validity and reliability of the Chinese (Singapore) version of the Parkinson's Disease Questionnaire (PDQ-39).

Authors:  N Luo; L C S Tan; S C Li; L K Soh; J Thumboo
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

4.  Impact of Depression on Progression of Impairment and Disability in Early Parkinson's Disease.

Authors:  Danny Bega; Sheng Luo; Hubert Fernandez; Kelvin Chou; Michael Aminoff; Sotirios Parashos; Harrison Walker; David S Russell; Chadwick W Christine; Rohit Dhall; Carlos Singer; Ivan Bodis-Wollner; Robert Hamill; Daniel Truong; Zoltan Mari; Sofya Glazmann; Meilin Huang; Emily Houston; Tanya Simuni
Journal:  Mov Disord Clin Pract       Date:  2015-07-14

5.  Uncovering indicators of the international classification of functioning, disability, and health from the 39-item Parkinson's disease questionnaire.

Authors:  Maria H Nilsson; Albert Westergren; Gunilla Carlsson; Peter Hagell
Journal:  Parkinsons Dis       Date:  2010-07-12

6.  Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.

Authors:  Jordan J Elm
Journal:  Mov Disord       Date:  2012-10       Impact factor: 10.338

7.  Rankin scale as a potential measure of global disability in early Parkinson's disease.

Authors:  Tanya Simuni; Sheng T Luo; Kelvin L Chou; Hubert Fernandez; Bo He; Sotirios Parashos
Journal:  J Clin Neurosci       Date:  2013-06-26       Impact factor: 1.961

8.  Two questionnaires for Parkinson's disease: are the PDQ-39 and PDQL equivalent?

Authors:  Pablo Martinez-Martin; Marcos Serrano-Dueñas; Maria João Forjaz; Maria Soledad Serrano
Journal:  Qual Life Res       Date:  2007-05-30       Impact factor: 4.147

9.  The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine.

Authors:  Peter Hagell; Carita Nygren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-18       Impact factor: 10.154

10.  Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39).

Authors:  Ulle Krikmann; Pille Taba; Taavi Lai; Toomas Asser
Journal:  Health Qual Life Outcomes       Date:  2008-03-25       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.